- Shares of Can-Fite BioPharma Ltd. CANF surged 12.8% after the company announced pre-clinical data from the Hadassah Medical Center lab reveal that Namodenoson induces weight loss.
- Shares of Lamb Weston Holdings, Inc. LW gained 11.3% after the company delivered Q2 fiscal 2020 adjusted earnings of 95 cents per share, surpassing the Zacks Consensus Estimate of 85 cents.
- Shares of Incyte Corporation INCY declined 9.4% after the company revealed that Itacitinib did not statistically improve overall response rate or non-relapse mortality compared to placebo in Phase 3 study.
- Shares of Novan, Inc. NOVN declined 73.1% after the company revealed top-line efficacy results from the Phase 3 B-SIMPLE program that evaluated SB206 for the treatment of molluscum contagiosum, which disclosed that statistical significance was not achieved for the primary endpoint in either B-SIMPLE1 or B-SIMPLE2.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Lamb Weston Holdings Inc. (LW) : Free Stock Analysis Report
Incyte Corporation (INCY) : Free Stock Analysis Report
Novan Inc. (NOVN) : Free Stock Analysis Report
Can-Fite Biopharma Ltd (CANF) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research